Pacer Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$14,336,745
+1.7%
926,745
+3.3%
0.06%
-3.5%
Q2 2023$14,100,259
-45.7%
897,534
-43.1%
0.06%
-48.6%
Q1 2023$25,986,801
+62.3%
1,576,869
+53.6%
0.11%
+35.4%
Q4 2022$16,010,233
+13.5%
1,026,297
-5.6%
0.08%
-16.3%
Q3 2022$14,106,000
+18.7%
1,087,582
+28.5%
0.10%
+11.4%
Q2 2022$11,881,000
+94.5%
846,256
+98.4%
0.09%
+76.0%
Q1 2022$6,107,000
+68.7%
426,458
+60.6%
0.05%
+35.1%
Q4 2021$3,620,000
+41.2%
265,562
+69.7%
0.04%
+15.6%
Q3 2021$2,563,000
-3.8%
156,467
-1.2%
0.03%
-15.8%
Q2 2021$2,664,000
+10.4%
158,290
+19.8%
0.04%
-9.5%
Q1 2021$2,413,000
-4.8%
132,126
-5.2%
0.04%
-12.5%
Q4 2020$2,535,000
+345.5%
139,311
+337.0%
0.05%
+300.0%
Q3 2020$569,000
+19.5%
31,876
+32.1%
0.01%
-45.5%
Q4 2019$476,000
+62.5%
24,123
+41.7%
0.02%
+214.3%
Q3 2019$293,000
+51.8%
17,023
+55.7%
0.01%
+40.0%
Q2 2019$193,000
-89.8%
10,932
-88.3%
0.01%
-90.6%
Q1 2019$1,901,000
+18.7%
93,305
-2.0%
0.05%
-5.4%
Q4 2018$1,601,000
-31.8%
95,192
-13.4%
0.06%
-36.4%
Q3 2018$2,349,000
+12.2%
109,912
+9.7%
0.09%
-7.4%
Q2 2018$2,094,000100,2210.10%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders